Evidence map›Paper›PMID 36512034›Full record

ArticleThe Journal of experimental medicine2023

Antibody feedback contributes to facilitating the development of Omicron-reactive memory B cells in SARS-CoV-2 mRNA vaccinees.

Takeshi Inoue, Ryo Shinnakasu, Chie Kawai, Hiromi Yamamoto, Shuhei Sakakibara, Chikako Ono, Yumi Itoh, Tommy Terooatea, Kazuo Yamashita, Toru Okamoto and 10 more

Abstract read
In one paragraph

Article in The Journal of experimental medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Antibody feedback establishes an affinity brake in the germinal center.bioRxiv : the preprint server for biology · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Influenza virus antibodies inhibit antigen-specificbioRxiv : the preprint server for biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Takeshi InoueLaboratory of Lymphocyte Differentiation, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan.ORCID 0000-0002-9972-6105
Ryo ShinnakasuLaboratory of Lymphocyte Differentiation, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan.ORCID 0000-0002-5369-3424
Chie KawaiLaboratory of Lymphocyte Differentiation, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan.ORCID 0000-0001-5883-2377
Hiromi YamamotoLaboratory of Lymphocyte Differentiation, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan.ORCID 0000-0002-3495-9936
Shuhei SakakibaraLaboratory of Immune Regulation, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan.ORCID 0000-0003-3157-5870
Chikako OnoLaboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.ORCID 0000-0002-3965-6715
Yumi ItohInstitute for Advanced Co-Creation Studies, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.ORCID 0000-0001-5501-3413
Tommy TerooateaKOTAI Biotechnologies, Inc., Osaka, Japan.ORCID 0000-0002-7814-3736
Kazuo YamashitaKOTAI Biotechnologies, Inc., Osaka, Japan.ORCID 0000-0002-0085-2057
Toru OkamotoInstitute for Advanced Co-Creation Studies, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.ORCID 0000-0003-4000-3102
Noritaka HashiiDivision of Biological Chemistry and Biologicals, National Institute of Health Sciences, Kanagawa, Japan.ORCID 0000-0003-1363-2050
Akiko Ishii-WatabeDivision of Biological Chemistry and Biologicals, National Institute of Health Sciences, Kanagawa, Japan.ORCID 0000-0003-2167-2263
Noah S ButlerDepartment of Microbiology and Immunology, The University of Iowa, Iowa City, IA, USA.ORCID 0000-0002-1429-0796
Yoshiharu MatsuuraLaboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.ORCID 0000-0001-9091-8285
Hisatake MatsumotoDepartment of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.ORCID 0000-0001-5771-570X
Shinya OtsukaDepartment of Surgery, National Hospital Organization Hakodate National Hospital, Hokkaido, Japan.ORCID 0000-0002-2489-9992
Kei HiraokaDepartment of Surgery, National Hospital Organization Hakodate National Hospital, Hokkaido, Japan.ORCID 0000-0002-5378-0421
Takanori TeshimaDivision of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan.ORCID 0000-0002-0941-271X
Masaaki MurakamiMolecular Psychoimmunology, Institute for Genetic Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.ORCID 0000-0001-7159-7279
Tomohiro KurosakiLaboratory of Lymphocyte Differentiation, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan.ORCID 0000-0002-6352-304X

Funding

Regulation of Plasmodium-specific CD4+ T CellsR01AI127481 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Noah Sullivan Butler · 2016 to 2026
$3.8M
Development and function of CD4+ memory T cells during malariaR01AI125446 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Noah Sullivan Butler · 2016 to 2026
$3.7M
Mechanisms and consequences of extrafollicular B cell activation during malariaR01AI167058 · NIAID · UNIVERSITY OF IOWA · PI BUTLER, NOAH SULLIVAN · 2021 to 2025
$3.2M
NIAID NIH HHS R01 AI125446NIAID NIH HHS R01 AI127481NIAID NIH HHS R01 AI167058
6 · The paper itself

Abstract

In contrast to a second dose of the SARS-CoV-2 mRNA vaccine, a third dose elicits potent neutralizing activity against the Omicron variant. To address the underlying mechanism for this differential antibody response, we examined spike receptor-binding domain (RBD)-specific memory B cells in vaccinated individuals. Frequency of Omicron-reactive memory B cells increased ∼9 mo after the second vaccine dose. These memory B cells show an altered distribution of epitopes from pre-second memory B cells, presumably due to an antibody feedback mechanism. This hypothesis was tested using mouse models, showing that an addition or a depletion of RBD-induced serum antibodies results in a concomitant increase or decrease, respectively, of Omicron-reactive germinal center (GC) and memory B cells. Our data suggest that pre-generated antibodies modulate the selection of GC and subsequent memory B cells after the second vaccine dose, accumulating more Omicron-reactive memory B cells over time, which contributes to the generation of Omicron-neutralizing antibodies elicited by the third vaccine dose.

Indexed as

COVID-19COVID-19 VaccinesAnimalsAntibodies, NeutralizingAntibodies, ViralFeedbackHumansMemory B CellsMiceRNA, MessengerSARS-CoV-2Antibodies, NeutralizingAntibodies, ViralCOVID-19 VaccinesRNA, Messenger

Identifiers

PMID36512034
PMCPMC9750191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.